Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Oct;83(10):1153–1158. doi: 10.1136/bjo.83.10.1153

Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis

J Ambati 1, K Wynne 1, M Angerame 1, M Robinson 1
PMCID: PMC1722828  PMID: 10502577

Abstract

AIM—Intravenous cidofovir is used to treat cytomegalovirus (CMV) retinitis, and has been reported to cause anterior uveitis. Relations were sought between this complication and patient characteristics that might help predict its occurrence.
METHODS—17 patients with AIDS and CMV retinitis who were treated with intravenous cidofovir were identified, and the following data collected in a retrospective chart review: demographic characteristics, duration of CMV retinitis, retinal lesion characteristics, dose and duration of cidofovir therapy, tests of renal function, CD4+ T lymphocyte counts, visual acuity, intraocular pressure, iris colour, history of diabetes mellitus, and use of concomitant medications. Case-control analyses were performed to determine risk factors for developing cidofovir associated uveitis.
RESULTS—Anterior uveitis characterised by pain, ciliary injection, and decreased visual acuity occurred in 10 patients (59%). Median interval to development of uveitis was 11 doses of cidofovir. Symptoms developed 4.4 (SD 2.5) days (median 3.5) after an infusion of cidofovir. Patients who developed uveitis had a significantly greater rise in CD4+ T lymphocyte count while receiving cidofovir (68.4 (75.7) ×106/l versus 5.0 (0.6) ×106/l, (p = 0.04)). By stepwise linear regression, this factor accounted for 33% (p = 0.03) of the effect of developing uveitis. Mean follow up time, intraocular pressure decline during cidofovir therapy, serum creatinine and urine protein concentrations, and rates of protease inhibitor use were not significantly different between patients who developed uveitis and those who did not. Uveitis responded to topical corticosteroids and cycloplegia.
CONCLUSION—Anterior uveitis in patients receiving intravenous cidofovir therapy may be related to improving immune function. The uveitis responds to treatment and may not preclude continuation of cidofovir.



Full Text

The Full Text of this article is available as a PDF (98.9 KB).

Figure 1  .

Figure 1  

Open in a new tab

Scatter plot of change in CD4+ T lymphocyte count from baseline to time of uveitis (or maximal level in patients without uveitis).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akler M. E., Johnson D. W., Burman W. J., Johnson S. C. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology. 1998 Apr;105(4):651–657. doi: 10.1016/S0161-6420(98)94019-2. [DOI] [PubMed] [Google Scholar]
  2. Atalla L., Linker-Israeli M., Steinman L., Rao N. A. Inhibition of autoimmune uveitis by anti-CD4 antibody. Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1264–1270. [PubMed] [Google Scholar]
  3. Banker A. S., Arevalo J. F., Munguia D., Rahhal F. M., Ishimoto B., Berry C., De Clercq E., Ochabski R., Taskintuna I., Freeman W. R. Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis. Am J Ophthalmol. 1997 Aug;124(2):168–180. doi: 10.1016/s0002-9394(14)70781-0. [DOI] [PubMed] [Google Scholar]
  4. Cassoux N., Lumbroso L., Bodaghi B., Zazoun L., Katlama C., LeHoang P. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy. Br J Ophthalmol. 1999 Jan;83(1):47–49. doi: 10.1136/bjo.83.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chaknis M. J., Brooks S. E., Mitchell K. T., Marcus D. M. Inflammatory opacities of the vitreous in rifabutin-associated uveitis. Am J Ophthalmol. 1996 Oct;122(4):580–582. doi: 10.1016/s0002-9394(14)72124-5. [DOI] [PubMed] [Google Scholar]
  6. Chan C. C., Hikita N., Dastgheib K., Whitcup S. M., Gery I., Nussenblatt R. B. Experimental melanin-protein-induced uveitis in the Lewis rat. Immunopathologic processes. Ophthalmology. 1994 Jul;101(7):1275–1280. doi: 10.1016/s0161-6420(94)31199-7. [DOI] [PubMed] [Google Scholar]
  7. Chavez-de la Paz E., Arevalo J. F., Kirsch L. S., Munguia D., Rahhal F. M., De Clercq E., Freeman W. R. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. Ophthalmology. 1997 Mar;104(3):539–544. doi: 10.1016/s0161-6420(97)30278-4. [DOI] [PubMed] [Google Scholar]
  8. Cundy K. C., Li Z. H., Lee W. A. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits. Drug Metab Dispos. 1996 Mar;24(3):315–321. [PubMed] [Google Scholar]
  9. Davis J. L., Taskintuna I., Freeman W. R., Weinberg D. V., Feuer W. J., Leonard R. E. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol. 1997 Jun;115(6):733–737. doi: 10.1001/archopht.1997.01100150735008. [DOI] [PubMed] [Google Scholar]
  10. Freeman W. R. New developments in the treatment of CMV retinitis. Ophthalmology. 1996 Jul;103(7):999–1000. doi: 10.1016/s0161-6420(96)30548-4. [DOI] [PubMed] [Google Scholar]
  11. Fujikawa L. S., Haugen J. P. Immunopathology of vitreous and retinochoroidal biopsy in posterior uveitis. Ophthalmology. 1990 Dec;97(12):1644–1653. doi: 10.1016/s0161-6420(90)32357-6. [DOI] [PubMed] [Google Scholar]
  12. Gariano R. F., Cooney E. L. Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS. Clin Infect Dis. 1997 Mar;24(3):529–529. doi: 10.1093/clinids/24.3.529. [DOI] [PubMed] [Google Scholar]
  13. HOGAN M. J., KIMURA S. J., THYGESON P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol. 1959 May;47(5 Pt 2):155–170. doi: 10.1016/s0002-9394(14)78239-x. [DOI] [PubMed] [Google Scholar]
  14. Henderson H. W., Mitchell S. M. Treatment of immune recovery vitritis with local steroids. Br J Ophthalmol. 1999 May;83(5):540–545. doi: 10.1136/bjo.83.5.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Herbort C. P., Chave J. P. Cicatrization of cytomegalovirus retinitis following introduction of highly active anti-retroviral therapy: uveitis as a possible indicator of good ocular prognosis. Graefes Arch Clin Exp Ophthalmol. 1998 Oct;236(10):795–797. doi: 10.1007/s004170050161. [DOI] [PubMed] [Google Scholar]
  16. Holladay J. T., Prager T. C. Mean visual acuity. Am J Ophthalmol. 1991 Mar 15;111(3):372–374. doi: 10.1016/s0002-9394(14)72328-1. [DOI] [PubMed] [Google Scholar]
  17. Holland G. N., Buhles W. C., Jr, Mastre B., Kaplan H. J. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol. 1989 Dec;107(12):1759–1766. doi: 10.1001/archopht.1989.01070020841024. [DOI] [PubMed] [Google Scholar]
  18. Karavellas M. P., Lowder C. Y., Macdonald C., Avila C. P., Jr, Freeman W. R. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol. 1998 Feb;116(2):169–175. doi: 10.1001/archopht.116.2.169. [DOI] [PubMed] [Google Scholar]
  19. Kim M. C., Kabeer N. H., Tandhasetti M. T., Kaplan H. J., Bora N. S. Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res. 1995 Aug;14(8):703–710. doi: 10.3109/02713689508998498. [DOI] [PubMed] [Google Scholar]
  20. Kirsch L. S., Arevalo J. F., Chavez de la Paz E., Munguia D., de Clercq E., Freeman W. R. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1995 Apr;102(4):533–543. doi: 10.1016/s0161-6420(95)30985-2. [DOI] [PubMed] [Google Scholar]
  21. Lalezari J. P., Stagg R. J., Kuppermann B. D., Holland G. N., Kramer F., Ives D. V., Youle M., Robinson M. R., Drew W. L., Jaffe H. S. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997 Feb 15;126(4):257–263. doi: 10.7326/0003-4819-126-4-199702150-00001. [DOI] [PubMed] [Google Scholar]
  22. Macdonald J. C., Torriani F. J., Morse L. S., Karavellas M. P., Reed J. B., Freeman W. R. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis. 1998 May;177(5):1182–1187. doi: 10.1086/515281. [DOI] [PubMed] [Google Scholar]
  23. Magone M. T., Nussenblatt R. B., Whitcup S. M. Elevation of laser flare photometry in patients with cytomegalovirus retinitis and AIDS. Am J Ophthalmol. 1997 Aug;124(2):190–198. doi: 10.1016/s0002-9394(14)70783-4. [DOI] [PubMed] [Google Scholar]
  24. Nussenblatt R. B. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3131–3141. [PubMed] [Google Scholar]
  25. Ohta K., Norose K., Wang X. C., Ito S., Yano A., Segawa K. Apoptosis-related fas antigen on memory T cells in aqueous humor of uveitis patients. Curr Eye Res. 1996 Mar;15(3):299–306. doi: 10.3109/02713689609007624. [DOI] [PubMed] [Google Scholar]
  26. Piscitelli S. C., Flexner C., Minor J. R., Polis M. A., Masur H. Drug interactions in patients infected with human immunodeficiency virus. Clin Infect Dis. 1996 Oct;23(4):685–693. doi: 10.1093/clinids/23.4.685. [DOI] [PubMed] [Google Scholar]
  27. Rahhal F. M., Arevalo J. F., Chavez de la Paz E., Munguia D., Azen S. P., Freeman W. R. Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report. Ann Intern Med. 1996 Jul 15;125(2):98–103. doi: 10.7326/0003-4819-125-2-199607150-00003. [DOI] [PubMed] [Google Scholar]
  28. Rosenbaum J. T. Drug-induced uveitis: reporting inflammation while avoiding inflammatory reports. Am J Ophthalmol. 1994 Dec 15;118(6):805–806. doi: 10.1016/s0002-9394(14)72562-0. [DOI] [PubMed] [Google Scholar]
  29. Shafran S. D., Singer J., Zarowny D. P., Phillips P., Salit I., Walmsley S. L., Fong I. W., Gill M. J., Rachlis A. R., Lalonde R. G. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. N Engl J Med. 1996 Aug 8;335(6):377–383. doi: 10.1056/NEJM199608083350602. [DOI] [PubMed] [Google Scholar]
  30. Taskintuna I., Banker A. S., Rao N. A., Wiley C. A., Flores-Aguilar M., Munguia D., Bergeron-Lynn G., De Clercq E., Keefe K., Freeman W. R. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects. Exp Eye Res. 1997 May;64(5):795–806. doi: 10.1006/exer.1996.0273. [DOI] [PubMed] [Google Scholar]
  31. Vrabec T. R., Baldassano V. F., Whitcup S. M. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology. 1998 Jul;105(7):1259–1264. doi: 10.1016/S0161-6420(98)97031-2. [DOI] [PubMed] [Google Scholar]
  32. Westheimer G. Scaling of visual acuity measurements. Arch Ophthalmol. 1979 Feb;97(2):327–330. doi: 10.1001/archopht.1979.01020010173020. [DOI] [PubMed] [Google Scholar]
  33. Zegans M. E., Walton R. C., Holland G. N., O'Donnell J. J., Jacobson M. A., Margolis T. P. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1998 Mar;125(3):292–300. doi: 10.1016/s0002-9394(99)80134-2. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES